CAS 924377-85-5

GSK1702934A

CAS: 924377-85-5

GSK1702934A

Reinheit: ≥98%

Molekulargewicht: 395.52g/mol

Ref: 54-BUP21847

GSK 1702934a

CAS: 924377-85-5

GSK 1702934A is a highly selective antagonist, which is derived from GlaxoSmithKline's series of research compounds targeting specific neuronal pathways. It primarily functions by inhibiting the activity of orexin receptors, particularly orexin 1 receptor (OX1R). This selective antagonism allows for precise modulation of the orexinergic system, which is pivotal in regulating various physiological processes such as sleep-wake cycles, appetite, and stress response.

Formel: C₂₂H₂₅N₃O₂S

Reinheit: Min. 95%

Molekulargewicht: 395.5 g/mol

Ref: 3D-ZLB37785

GSK1702934A

CAS: 924377-85-5

GSK1702934A is a TRPC3 agonist with pro-arrhythmic and positive inotropic effects and is used in the study of diabetes mellitus.

Formel: C₂₂H₂₅N₃O₂S

Reinheit: 98.15%

Farbe und Form: Solid

Molekulargewicht: 395.52

Ref: TM-T15425